BioNTech SE
Biotechnology / ImmunotherapyFounded 2008- Updated July 2025
Reviewed by Swet Parvadiya
Last reviewed: July 2025
CorpDigest
BioNTech SE
Annual Revenue
Last reviewed: 2025-07-15 · By Swet Parvadiya
FY2023 Revenue
$4.2B
▼ 78% vs FY2022 ($18.9B)
BioNTech SE reported $4.2B in revenue for fiscal year 2023. This represents a decline of 78% compared to the 2022 figure of $18.9B. In 2024, revenue declined to $3.0B.
Source: SEC EDGAR filings, annual earnings releases, and verified financial disclosures.